Perfil
Scott Filosi is currently the Chief Executive Officer at Diaccurate SA since 2023.
He also holds a current position as the Head-Global Market Access & Pricing at Merck KGaA.
Previously, he worked at Merck KGaA as the Head-Global Market Access & Pricing.
Cargos activos de Scott Filosi
| Empresas | Cargo | Inicio |
|---|---|---|
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Director Ejecutivo | 06/11/2023 |
Antiguos cargos conocidos de Scott Filosi.
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01/05/2019 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Empresas privadas | 1 |
|---|---|
Diaccurate SA
Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Filosi
